First Amgen Scholars Program in India launches at IIIT Hyderabad
Amgen announced the launch of the first Amgen Scholars Program in India at the International Institute of Information Technology…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Amgen
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD:…
GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…
Lerodalcibep can be a treatment option for patients requiring additional LDL-C reduction: GlobalData
Lerodalcibep is a novel therapy designed to lower low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic…
Amgen launches $200 million technology and innovation hub in Hyderabad
The new Amgen India site will enhance global digital capabilities through AI and data science, creating opportunities for local…
Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Corlanor Tablets, 5 mg and 7.5 mg, of…
Amgen to open a new site in Hyderabad
The site, known as Amgen India, aims to accelerate digital capabilities across the global organisation to further advance Amgen’s…
USFDA grants approval of Bkemv to Amgen
Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases
Veeda Board appoints Dr Mahesh Bhalgat as Group CEO
Prior to joining Veeda, he was the COO for Syngene International (Biocon Group Company)
Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
The latest data from the final analysis of the Phase II OCEAN(a)-DOSE study showed that olpasiran reduced Lp(a) levels in patients…